Non–Small Cell Lung Cancer, Version 6.2015
作者： David S Ettinger , Douglas E Wood , Wallace Akerley , Lyudmila A Bazhenova , Hossein Borghaei
关键词:
摘要: These NCCN Guidelines Insights focus on recent updates to the 2015 for Non-Small Cell Lung Cancer (NSCLC). Appropriate targeted therapy is very effective in patients with advanced NSCLC who have specific genetic alterations. Therefore, it important test tumor tissue from determine whether they alterations that make them candidates therapies. describe different testing methods currently available determining 2 most commonly actionable alterations, notably anaplastic lymphoma kinase (ALK) gene rearrangements and sensitizing epidermal growth factor receptor (EGFR) mutations.
elsevier.com
sci-hub.se 参考文章(79)
M. G. Kris, D. S. Ettinger, Ritsuko Komaki, R. J. Ginsberg, D. J. Sugarbaker, R. B. Livingston, J. D. Cox, NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology. ,vol. 10, pp. 81- 111 ,(1996)
Eugen C. Minca, Bryce P. Portier, Zhen Wang, Christopher Lanigan, Carol F. Farver, Yan Feng, Patrick C. Ma, Valeria A. Arrossi, Nathan A. Pennell, Raymond R. Tubbs, ALK Status Testing in Non–Small Cell Lung Carcinoma: Correlation Between Ultrasensitive IHC and FISH The Journal of Molecular Diagnostics. ,vol. 15, pp. 341- 346 ,(2013) , 10.1016/J.JMOLDX.2013.01.004
, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873
Hussam Al-Kateb, TuDung T. Nguyen, Eric J. Duncavage, Catherine E. Cottrell, Shashikant Kulkarni, Rakesh Nagarajan, Karen Seibert, Maria Baggstrom, Saiama N. Waqar, John D. Pfeifer, Daniel Morgensztern, Ramaswamy Govindan, Ian S. Hagemann, Siddhartha Devarakonda, Christina M. Lockwood, David H. Spencer, Kalin Guebert, Andrew J. Bredemeyer, Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer. ,vol. 121, pp. 631- 639 ,(2015) , 10.1002/CNCR.29089
Andrew J. Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella-Garcia, Robert C. Doebele, D. Ross Camidge, Diagnostic assays for identification of anaplastic lymphoma kinase-positive non–small cell lung cancer Cancer. ,vol. 119, pp. 1467- 1477 ,(2013) , 10.1002/CNCR.27913
Liza C. Villaruz, Mark A. Socinski, Shira Abberbock, Lynne D. Berry, Bruce E. Johnson, David J. Kwiatkowski, A. John Iafrate, Marileila Varella-Garcia, Wilbur A. Franklin, D. Ross Camidge, Lecia V. Sequist, Eric B. Haura, Mark Ladanyi, Brenda F. Kurland, Kelly Kugler, John D. Minna, Paul A. Bunn, Mark G. Kris, Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium Cancer. ,vol. 121, pp. 448- 456 ,(2015) , 10.1002/CNCR.29042
Douglas E. Wood, Ella Kazerooni, Scott L. Baum, Mark T. Dransfield, George A. Eapen, David S. Ettinger, Lifang Hou, David M. Jackman, Donald Klippenstein, Rohit Kumar, Rudy P. Lackner, Lorriana E. Leard, Ann N.C. Leung, Samir S. Makani, Pierre P. Massion, Bryan F. Meyers, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Peter B. Sachs, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes, Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. Journal of The National Comprehensive Cancer Network. ,vol. 13, pp. 23- 34 ,(2015) , 10.6004/JNCCN.2015.0006
Takamitsu Onitsuka, Hidetaka Uramoto, Naohiro Nose, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto, Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status Lung Cancer. ,vol. 68, pp. 198- 203 ,(2010) , 10.1016/J.LUNGCAN.2009.05.022
William Pao, Marc Ladanyi, Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clinical Cancer Research. ,vol. 13, pp. 4954- 4955 ,(2007) , 10.1158/1078-0432.CCR-07-1387
Alice T. Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas, Gregory J. Riely, Benjamin J. Solomon, Juergen Wolf, Michael Thomas, Martin Schuler, Geoffrey Liu, Armando Santoro, Yvonne Y. Lau, Meredith Goldwasser, Anthony L. Boral, Jeffrey A. Engelman, Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 370, pp. 1189- 1197 ,(2014) , 10.1056/NEJMOA1311107